Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Ami Amit
42 years of experience
accreditations :
Clinic is certified :
Dr. Ami Amit is a leading cardiologist and Chairman of Interventional Cardiology at Medanta - The Medicity, credited with pioneering new devices in India.
43 years of experience of experience in gynecology – Dr. Volman is a professor at Tel Aviv University and a leading obstetrician at Sourasky Medical Center.
A clinical professor at Tel Aviv University who led groundbreaking research at a New York hospital. Dr. Osnat offers specialized care from a top academic perspective.
Prof. Roy Mashiach, MD, is the Director of Gynecology at Sheba Medical Center. He is a leading expert in minimally invasive gynecologic surgery with over 30 years of experience. He focuses on laparoscopic and hysteroscopic hysterectomy. He also performs myoma removal, treats endometriosis, and offers fertility‑preserving procedures.
Recognition and roles: Named to Forbes Israel’s Best Doctors. Recipient of the Daniel F. Kott Award (AAGL). Chairman of the Israeli Society of Gynecological Endoscopy. Director of the Gynecologic Simulation Unit (M.S.R.). Clinical Associate Professor at Tel Aviv University. Training: MD from Tel Aviv University. Specialization at Lis Maternity & Women’s Hospital. Fellowship in Advanced Endoscopy at Université d’Auvergne.
Primary treatment methods for fibroadenoma in Israel emphasize breast conservation through cryoablation and vacuum-assisted biopsy. Specialists at JCI-accredited centers like Assuta and Sourasky prioritize hormone profiling and advanced imaging. These techniques ensure precise diagnosis while minimizing physical scarring for patients with benign breast lumps.
Bookimed Expert Insight: Israeli oncology centers maintain a 90% success rate by integrating diagnostic imaging with local treatments. Clinics like Sourasky treat over 400,000 patients annually using Nobel Prize-winning medical expertise. For small, stable fibroadenomas, Israeli protocols often favor serial ultrasounds over surgery to maintain natural breast tissue.
Patient Consensus: Patients note it is important to track size and hormone changes yourself before choosing surgery. Many suggest consulting multiple doctors, as stable fibroadenomas often require only regular monitoring rather than immediate removal.
Removal of a fibroadenoma is recommended when the lump exceeds 3 cm, grows rapidly, or causes persistent pain. Israeli specialists advise surgery if imaging cannot definitively rule out a phyllodes tumor. Diagnostic verification via core biopsy remains a required step before any surgical intervention.
Bookimed Expert Insight: Israeli medical centers like Sourasky and Assuta offer a clear choice between heavy-volume public facilities and specialized private care for fibroadenoma. Large centers like Sourasky manage over 1,800,000 patients annually, ensuring deep diagnostic expertise with complex cases. However, patients often prefer private clinics like Assuta for surgical removal. This allows them to choose a specific attending physician, such as Dr. Yigal Volman, who has over 25 years of experience.
Patient Consensus: Patients emphasize the peace of mind gained from removal when lumps exceed 3 cm or cause anxiety. Many prefer vacuum-assisted excision to avoid scarring while maintaining 6-month ultrasound monitoring for smaller, stable masses.
Fibroadenoma treatment in Israel demonstrates high clinical success. Leading Israeli oncology centers report a 90% average success rate for oncology-related procedures. Local recurrence for breast-conserving techniques remains low. Specialists utilize precise digital imaging to ensure complete removal of benign lesions during surgery.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center function as scientific hubs where doctors invent new treatments. This culture of innovation ensures patients access refined surgical techniques before they become global standards. High patient volumes of 1.8 million annually across departments correlate with the high 90% success rates reported.
Patient Consensus: Patients often mention feeling relieved by the speed of diagnostic hormonal testing and mammology consultations. They note that the focus on preserving breast aesthetics during the procedure is a major priority.
Recovery after fibroadenoma treatment in Israel is typically rapid. Most patients return to light activities in 2 to 4 days. Full healing is expected within 1 to 2 weeks. Minimally invasive techniques like cryotherapy allow for even faster recovery within 72 hours.
Bookimed Expert Insight: Israeli centers like Sourasky Medical Center and Assuta prioritize outpatient surgical care. This allows over 90% of oncology and tumor patients to bypass long stays. Data shows high-volume clinics performing over 30,000 surgeries annually use advanced techniques that minimize internal scarring. Choosing a private center often guarantees faster access to these minimally invasive options.
Patient Consensus: Patients note that even for large lumps, bruising fades quickly after the third day. Many emphasize wearing a soft sports bra to significantly reduce discomfort during the first week.
Diagnostic work-up in Israel requires a consultation with a mammologist and a hormonal profile blood test. Specialists use clinical breast exams and imaging to differentiate benign masses. Precise biopsy and pathology confirm the diagnosis before selecting surgical or non-invasive treatment options.
Bookimed Expert Insight: Israeli medical centers like Sourasky and Assuta handle massive patient volumes. Assuta alone performs 92,000 operations annually. This high internal activity means diagnostic teams recognize rare fibroadenoma variants quickly. Patients often benefit from this high-volume expertise through more accurate, rapid pathology results.
Patient Consensus: Patients note that ultrasound is the standard first step. Many emphasize the importance of requesting a biopsy if a lump is larger than 2 centimeters.
Leading Israeli facilities for fibroadenoma management include Sourasky Medical Center, Assuta Hospital, and Sheba Medical Center. These centers specialize in multidisciplinary breast health and high-volume surgical procedures. They utilize advanced diagnostics and offer both monitoring and minimally invasive removal for benign tumors.
Bookimed Expert Insight: Israeli private centers like Assuta offer a specific flexibility that public university hospitals often lack. Patients can choose their attending physician and specific room type. This choice is vital for fibroadenoma patients seeking specialists who favor minimally invasive vacuum-assisted excision over standard surgery. Since many of these doctors also work at larger centers like Sourasky, booking through a private facility often ensures direct access to these specific experts without the typical public wait times.
Patient Consensus: Patients note it is important to track lump size with scans every 6 months rather than rushing to surgery. Many women suggest getting a second ultrasound opinion to confirm a benign status before committing to a biopsy.
Cryoablation leaves minimal to no visible external scarring. Surgeons use a needle-like probe through a 3-millimeter incision. This tiny opening usually requires no stitches and heals rapidly. Patients typically notice only a faint mark that fades over several months into a nearly invisible scar.
Bookimed Expert Insight: While external marks are negligible, internal healing creates a temporary firm lump. Data from Sourasky Medical Center shows a 90% success rate in oncology-related procedures. This suggests that high-volume centers manage tissue preservation effectively. Patients should expect the internal scar to soften over 6 to 12 months as the body naturally clears treated cells.
Patient Consensus: Patients often mention feeling relieved that the procedure is much faster than expected. They report that the tiny incision site is easily covered by a standard adhesive bandage after treatment.